Rosetta Genomics (ROSG) Closes 5.5M Offering at $5/Share
Rosetta Genomics Ltd. (Nasdaq: ROSG), announced the closing of an underwritten public offering of 5,500,000 ordinary shares at an offering price of $5.00 per share. The gross proceeds to Rosetta were $27.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Rosetta. In addition, Rosetta has granted the underwriter a 45-day option to purchase up to 825,000 additional ordinary shares to cover over-allotments, if any.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brainstorm Cell Therapeutics (BCLI) Files 3.86M Common Shelf for Shareholders
- Synergy Resources (SYRG) Commences $150M Stock Offering
- Carnival Corp. (CCL) Enters MOU with China Merchants Group for China Cruise Market Expansion
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!